Oncology

Graphic image of a pen signing a signature while two strangelooking business people cheer
Biotech

Oncology biotech licenses Genevant tech for up to $123M

The goal of the deal is to develop new mRNA-lipid nanoparticle therapies for an undisclosed cancer indication.
Darren Incorvaia Dec 20, 2024 6:00am
Board room C-suite meeting contract

Boundless drops clinical-stage cancer drug, shakes up C-suite

Dec 13, 2024 7:30am
Belharra beach in France

40% layoffs break Belharra's tidal wave

Dec 9, 2024 4:52pm
handshake deal shake hand arrows ok yes

GSK offers Rgenta up to $500M biobucks per target in RNA deal

Dec 4, 2024 8:00am
trojan horse

Trogenix unveils odyssey to find 'one-and-done' tumor drugs

Nov 18, 2024 4:37am
Layoffs

Sensei lays off 46% of staff, closes site to fund cancer trial

Nov 14, 2024 9:38am
More News

Roche sparks $1.8B-plus discovery deal with Flare Therapeutics

Nov 12, 2024 7:00am

MD Anderson launches cell therapy institute with $80M

Nov 11, 2024 4:20pm

Medidata meshes services into oncology and vaccine trial bundles

Nov 5, 2024 3:40pm

Sana strips back cancer, CNS programs while warning of layoffs

Nov 5, 2024 7:05am